Lauren Hutchinson, MD
Plastic and Reconstructive Surgery · Shelby, NCNPI 1205241221
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,833 of the $7,805 with a category attached, or 61.9%. AbbVie accounts for 62.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $2,702 and has fallen 66.1% since, to $916 in 2025.
Across 108 payments — averaging $72.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Mentor Worldwide LLC$959
- Wardlow Enterprises$385
- Sientra, Inc.$288
- Integra Lifesciences Corporation$265
- Boehringer Ingelheim$114
- plus $886 from 20 others
Across 1 payment — averaging $5116.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mentor Worldwide LLC$5K
What the payments were for
- Travel & lodging$2,58733%
- Food & beverage$4,83362%
- Education$3855%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $4,908 |
| Mentor Worldwide LLC | 12 | $959 |
| Wardlow Enterprises | 1 | $385 |
| Sientra, Inc. | 4 | $288 |
| Integra Lifesciences Corporation | 10 | $265 |
| Boehringer Ingelheim | 5 | $114 |
| Organogenesis Inc. | 4 | $93 |
| TELA Bio, Inc. | 3 | $91 |
| Tepha Inc | 1 | $82 |
| Convatec Inc. | 2 | $75 |
| Checkpoint Surgical, Inc | 1 | $74 |
| Johnson & Johnson | 3 | $50 |
| Fresenius Kabi USA, LLC | 3 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $47 |
| Amgen | 2 | $46 |
| Lilly USA, LLC | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 2 | $39 |
| Solventum Corporation | 1 | $39 |
| Almirall LLC | 1 | $35 |
| UCB, Inc. | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $20 |
| Biofrontera Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$4,490
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$2,721
- REVOLVE$1,005
- ARTOURA Breast Tissue Expander$303
- MENTOR MemoryGel Resterilizable Gel Sizer$293
- MemoryGel Breast Implants$252
- ALLODERM$245
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$140
- NATRELLE$125
- BOTOX$125
- MENTOR CPX 2 Breast Tissue Expander$119
How this compares
$7,805 in reported general payments places this provider in the 70th percentile of 55 plastic and reconstructive surgery providers in North Carolina.
See all plastic and reconstructive surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 29 | $2,064 |
| Metronidazole | 11 | $538 |
| Cephalexin | 16 | $167 |
| Ketoconazole | 12 | $144 |
| Triamcinolone Acetonide | 11 | $121 |
| Doxycycline Hyclate | 22 | $97 |
| Oxycodone Hcl | 13 | $64 |
| ValacyclovirValacyclovir Hcl | 12 | $38 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Shelby
- Jeffrey MarcusDurham$3.3M
- Anuja AntonyCary$326K
- Peter ArnoldGreensboro$206K
- Joseph HunstadCharlotte$144K
- Charles HultmanRaleigh$70K
- Charles KaysWilmington$69K
- Brian CoanCary$41K
- Benjamin WoodRaleigh$23K
- Mark MorganWilmington$23K
- Michael ZennRaleigh$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.